Nucleus plus
  • Patient Care
  • About
 
 

11.24.22

FOLR1 a target for CAR T therapy in C/G model of pediatric AML

by ASTCT Science Highlights

Le Q, Hadland B, Smith JL, et al. CBFA2T3-GLIS2 Model of Pediatric Acute Megakaryoblastic Leukemia Identifies FOLR1 as a CAR T Cell Target. Journal of Clinical Investigation. 2022; (doi: 10.1172/JCI157101).

Scientists have identified FOLR1, a gene specific to CBFA2T3-GLIS2 (C/G) fusion oncoprotein, as a potential therapeutic target for acute megakaryoblastic leukemia (AML). Fusion oncoproteins are often implicated in pediatric AML, and xenograft models associate the C/G type with generally poor prognoses. The researchers note that expression of the protein stimulates transformation of hematopoietic stem/progenitor cells (CB HSPCs) in human cord blood in a way that invites particularly aggressive cancer, especially in babies and very young children. Chimeric antigen receptor T cells directed at FOLR1 performed well against C/G AML in in vitro and xenograft models, a pre-clinical sign of efficacy. Before the therapy can advance to the clinical phase, potential safety concerns must be addressed. The endothelial niche is important for promoting leukemic transformation of C/G-transduced CB HSPCs, with investigators noting this activity takes place in an endothelial cell co-culture. FOLR1 is also expressed in renal and pulmonary epithelium, which raises concern about toxicity.

Read More

Inflammatory Cytokine Levels “Increased in Atrial Fibrillation After CAR T Therapy
01.05.23
Inflammatory Cytokine Levels “Increased in Atrial Fibrillation After CAR T Therapy
by Eleanor Mayfield, ELS
Adoptive immunotherapy for AML using CAR.CD123-NK cells
12.22.22
Adoptive immunotherapy for AML using CAR.CD123-NK cells
by ASTCT Science Highlights
CRISPR-Cas9 Gene Editing Used to Refine Allogeneic CAR T Cells
12.21.22
CRISPR-Cas9 Gene Editing Used to Refine Allogeneic CAR T Cells
by Eleanor Mayfield, ELS
footer divider

ASTCT

American Society for Transplantation
and Cellular Therapy

330 North Wabash Avenue, Suite 2000
Chicago, IL 60611, USA
Phone: (312) 321-6820
Fax: (312) 673-6733

facebook youtube twitter linkedin
Login
Search